Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis.
Palladini G, Paiva B, Wechalekar A, Massa M, Milani P, Lasa M, Ravichandran S, Krsnik I, Basset M, Burgos L, Nuvolone M, Lecumberri R, Foli A, Puig N, Sesta MA, Bozzola M, Cascino P, Nevone A, Ripepi J, Berti P, Casarini S, Annibali O, Orfao A, San-Miguel J, Merlini G.
Palladini G, et al.
Blood Cancer J. 2021 Feb 16;11(2):34. doi: 10.1038/s41408-021-00428-0.
Blood Cancer J. 2021.
PMID: 33594045
Free PMC article.